Revance Therapeutics Inc (RVNC)

[vinmantoo]

One thing I had not appreciated is how word-of-mouth and patient specific treatment practice is. The combination, in off-label particularly, would almost certainly slow uptake, particularly switching. Eg in the post below the md notes it took 5 runs to get dosing right in his CD patient.

RVNC must have been able to figure out how to dose given the very positive clinical trial data in CD.